Öcal, Osman http://orcid.org/0000-0001-5234-1921
Ingrisch, Michael http://orcid.org/0000-0003-0268-9078
Ümütlü, Muzaffer Reha
Peynircioglu, Bora
Loewe, Christian
van Delden, Otto
Vandecaveye, Vincent
Gebauer, Bernhard
Zech, Christoph J.
Sengel, Christian
Bargellini, Irene
Iezzi, Roberto
Benito, Alberto
Pech, Maciej
Malfertheiner, Peter
Ricke, Jens
Seidensticker, Max http://orcid.org/0000-0002-2481-5410
Funding for this research was provided by:
Bayer
Article History
Received: 11 February 2021
Revised: 16 August 2021
Accepted: 30 September 2021
First Online: 22 October 2021
Ethics approval
: The study protocol was approved by the institutional review board of each participating centre and conducted in accordance with the Declaration of Helsinki. All patients gave written informed consent.
: BG: personal fees—Bayer, Sirtex. IB: Grants—Sirtex, during the conduct of the study. Personal fees—Bayer, Sirtex, Biocompatibles, Terumo, outside the submitted work. MP: Grants—Sirtex, Bayer; Personal fees—Sirtex. PM: Grants—Bayer, Sirtex. JR: Grants—Sirtex, Bayer; Personal fees—Sirtex, Bayer. MS: Personal fees—Bayer, Sirtex.